JP Patent

JP2000502354A — ビトロネクチン受容体アンタゴニスト

Assigned to SmithKline Beecham Corp · Expires 2000-02-29 · 26y expired

What this patent protects

(57)【要約】 ビトロネクチン受容体アンタゴニストであり、骨粗鬆症の治療に有用な式（Ｉ〜Ｖ）の化合物を開示する。

USPTO Abstract

(57)【要約】 ビトロネクチン受容体アンタゴニストであり、骨粗鬆症の治療に有用な式（Ｉ〜Ｖ）の化合物を開示する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2000502354A
Jurisdiction
JP
Classification
—
Expires
2000-02-29
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.